Send me a link:

*Text messaging rates may apply.

 Dow Down 0.72% Nasdaq Down 0.50%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
2.59 Down 0.07(2.63%) Jul 25, 4:00PM EDT
Prev Close:2.66
Open:2.65
Bid:2.56 x 500
Ask:2.96 x 800
1y Target Est:4.90
Beta:1.64
Next Earnings Date:N/A
Day's Range:2.59 - 2.65
52wk Range:1.01 - 4.25
Volume:859,080
Avg Vol (3m):1,947,970
Market Cap:368.14M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CTIC

Comparison

Symbol% ChgMkt Cap
CTICDown 2.63%368.14M
BMYDown 0.14%81.85B
RHHBYDown 0.90%250.67B
SNYDown 2.04%134.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.81
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.60
Quarterly EPS Est (Jun-14) :-0.13
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CTI BioPharma Corp., a biopharmaceutical company, is engaged in the acquisition, development, and commercialization of treatments for cancer. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative, which is in ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback